Use of a deformable atlas to identify cryptic critical structures in the treatment of glioblastoma multiforme.

Dose constraints for traditional neural critical structures (e.g. optic chiasm, brain stem) are a standard component of planning radiation therapy to the central nervous system. Increasingly, investigators are becoming interested in accounting for the dose delivered to other non-target neural struct...

Full description

Bibliographic Details
Main Authors: David C Weksberg, Stephen D Bilton, Eric L Chang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3312881?pdf=render
id doaj-9edcac7d46df461dbdf6437cd6d61351
record_format Article
spelling doaj-9edcac7d46df461dbdf6437cd6d613512020-11-25T01:53:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0173e3209810.1371/journal.pone.0032098Use of a deformable atlas to identify cryptic critical structures in the treatment of glioblastoma multiforme.David C WeksbergStephen D BiltonEric L ChangDose constraints for traditional neural critical structures (e.g. optic chiasm, brain stem) are a standard component of planning radiation therapy to the central nervous system. Increasingly, investigators are becoming interested in accounting for the dose delivered to other non-target neural structures (e.g. hippocampi), which are not easily identified on axial imaging. In this pilot study, a commercially available digital atlas was used to identify cryptic neural structures (hippocampus, optic radiations, and visual cortices) in 6 patients who received intensity modulated radiation therapy (IMRT) as part of multimodal management of glioblastoma multiforme (GBM). The patient's original IMRT plans were re-optimized, with avoidance parameters for the newly identified critical structures. Re-optimization was able to reduce both mean and maximum dose to the volumes of interest, with a more pronounced effect for contralateral structures. Mean dose was reduced by 11% and 3% to contralateral and ipsilateral structures, respectively, with comparable reduction in maximum dose of 10% and 2%, respectively. Importantly, target coverage was not compromised, with an average change in coverage of 0.2%. Overall, our results demonstrate the feasibility of incorporating tools for cryptic critical structure identification into the treatment planning process for GBM.http://europepmc.org/articles/PMC3312881?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author David C Weksberg
Stephen D Bilton
Eric L Chang
spellingShingle David C Weksberg
Stephen D Bilton
Eric L Chang
Use of a deformable atlas to identify cryptic critical structures in the treatment of glioblastoma multiforme.
PLoS ONE
author_facet David C Weksberg
Stephen D Bilton
Eric L Chang
author_sort David C Weksberg
title Use of a deformable atlas to identify cryptic critical structures in the treatment of glioblastoma multiforme.
title_short Use of a deformable atlas to identify cryptic critical structures in the treatment of glioblastoma multiforme.
title_full Use of a deformable atlas to identify cryptic critical structures in the treatment of glioblastoma multiforme.
title_fullStr Use of a deformable atlas to identify cryptic critical structures in the treatment of glioblastoma multiforme.
title_full_unstemmed Use of a deformable atlas to identify cryptic critical structures in the treatment of glioblastoma multiforme.
title_sort use of a deformable atlas to identify cryptic critical structures in the treatment of glioblastoma multiforme.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2012-01-01
description Dose constraints for traditional neural critical structures (e.g. optic chiasm, brain stem) are a standard component of planning radiation therapy to the central nervous system. Increasingly, investigators are becoming interested in accounting for the dose delivered to other non-target neural structures (e.g. hippocampi), which are not easily identified on axial imaging. In this pilot study, a commercially available digital atlas was used to identify cryptic neural structures (hippocampus, optic radiations, and visual cortices) in 6 patients who received intensity modulated radiation therapy (IMRT) as part of multimodal management of glioblastoma multiforme (GBM). The patient's original IMRT plans were re-optimized, with avoidance parameters for the newly identified critical structures. Re-optimization was able to reduce both mean and maximum dose to the volumes of interest, with a more pronounced effect for contralateral structures. Mean dose was reduced by 11% and 3% to contralateral and ipsilateral structures, respectively, with comparable reduction in maximum dose of 10% and 2%, respectively. Importantly, target coverage was not compromised, with an average change in coverage of 0.2%. Overall, our results demonstrate the feasibility of incorporating tools for cryptic critical structure identification into the treatment planning process for GBM.
url http://europepmc.org/articles/PMC3312881?pdf=render
work_keys_str_mv AT davidcweksberg useofadeformableatlastoidentifycrypticcriticalstructuresinthetreatmentofglioblastomamultiforme
AT stephendbilton useofadeformableatlastoidentifycrypticcriticalstructuresinthetreatmentofglioblastomamultiforme
AT ericlchang useofadeformableatlastoidentifycrypticcriticalstructuresinthetreatmentofglioblastomamultiforme
_version_ 1724990982161694720